• Thu. Apr 25th, 2024

IFF divests Cosmetics Ingredients business to Clariant, prioritizing innovation and growth

BySamantha Nguyen

Apr 3, 2024
IFF Successfully Divests its Cosmetics Ingredients Business

As part of its strategic transformation, IFF (NYSE: IFF) has successfully divested its Cosmetic Ingredients business to Clariant, a specialty chemicals company focused on sustainability. The sale of the business will enable IFF to make strategic growth investments, reduce debt, and lower interest costs.

Erik Fyrwald, CEO of IFF, highlighted the divestiture as a key step in prioritizing innovation and better serving target customers in core businesses. He expressed gratitude to the Cosmetics colleagues for their dedication to excellence and wished them success in their new journey with Clariant.

IFF is a global leader in food, beverage, health, biosciences, and scent experiences. Its team collaborates with customers to develop scents, tastes, experiences, ingredients, and solutions that the world craves. By leveraging art and science, IFF aims to do more good for people and the planet. Learn more about IFF on their website and social media channels.

For media inquiries, contact Paulina Heinkel at 332.877.5339 or media.request@iff.com. For investor relations, reach out to Michael Bender at 212.708.7263 or investor

By Samantha Nguyen

As a content writer at newsqwe.com, I am passionate about crafting engaging and informative articles that captivate our audience. With a background in journalism and a keen eye for detail, I strive to deliver content that is not only well-researched but also adds value to our readers' lives. From breaking news stories to in-depth features, I take pride in my ability to tell compelling stories that resonate with our diverse audience. When I'm not typing away at my keyboard, you can find me exploring new cafes, practicing yoga, or getting lost in a good book. I am thrilled to be a part of the newsqwe.com team and look forward to sharing my love for writing with all of our readers.

Leave a Reply